Patents Assigned to Therapeutical Systems Corp.
  • Patent number: 4724230
    Abstract: An improved method is described for producing oncolysis, including regression of malignant tumors or other malignant conditions, without adverse effects upon normal body cells. In addition to a calorically and compositionally defined nutritional regimen providing a minimum of amino acids and fatty acids and a maximum of carbohydrate, administered concurrently with a drug regimen of an agent or agents that uncouple oxidative phosphorylation (most preferably 2,4-dinitrophenol), there is also concurrently administered a selected amount of a substantially non-toxic fatty acid oxidation inhibitor capable of effectively lowering the mitochondrial .beta.-oxidation rate of fatty acids.
    Type: Grant
    Filed: July 25, 1984
    Date of Patent: February 9, 1988
    Assignee: Therapeutical Systems Corp.
    Inventor: Clarence D. Cone, Jr.
  • Patent number: 4724234
    Abstract: A method of producing oncolysis and regression of malignant tumors and other malignant conditions without adverse effects on normal body cells is described. A calorically and compositionally defined nutritional regimen providing a minimum of amino acids and fatty acids and a maximum of carbohydrates is administered concurrently with a drug regimen of an agent or agents that uncouple oxidative phosphorylation, most preferably 2,4-dinitrophenol.
    Type: Grant
    Filed: October 28, 1985
    Date of Patent: February 9, 1988
    Assignee: Therapeutical Systems Corp.
    Inventor: Clarence D. Cone, Jr.